EXPANSION IN TESTING PROCTOCOL FOR SYNTHETIC COMPOUNDS
Date Signed: 11/30/2012 | MARADMINS Number: 681/12
MARADMINS : 681/12
R 301458Z NOV 12 
UNCLASSIFIED/
MARADMIN 681/12
MSGID/GENADMIN,USMTF,2007/CMC WASHINGTON DC MRA MF(UC)/F002//
SUBJ/EXPANSION IN TESTING PROCTOCOL FOR SYNTHETIC COMPOUNDS//
REF/A/MSGID:DOC/CMC WASHINGTON DC MRA MF/YMD:20110411//
REF/B/MSGID:DOC/SECNAV INSTR/YMD:20110523//
NARR/REF A IS MCO 5300.17, MARINE CORPS SUBSTANCE ABUSE PROGRAM.  REFB IS SECNAV INSTRUCTION 5300.28E, MILITARY SUBSTANCE ABUSE PREVENTIONAND CONTROL//
POC/ERIC HOLLINS/CIV/UNIT:MFC-4/-/TEL:703-784-9526//
GENTEXT/REMARKS/1.  THIS MARADMIN ANNOUNCES A CHANGE IN URINALYSIS TESTING FOR SYNTHETIC CHEMICAL COMPOUNDS SUCH AS SPICE. 
2.  URINALYSIS TESTING FOR SYNTHETIC COMPOUNDS IS SEPARATE AND DISTINCT FROM THE URINALYSIS PROGRAM DIRECTED UNDER THE REFERENCES. TESTING WILL COMMENCE IN DECEMBER 2012, USING THE MODEL CURRENTLY IN PLACE FOR STEROID TESTING.
3.  UNDER THIS PROTOCOL, THERE IS NO LONGER A REQUIREMENT FOR SAMPLES TO BE ATTACHED TO AN ACTIVE INVESTIGATION, WHICH THE CURRENT PROTOCOLREQUIRES. 
4.  COMMANDERS, COMMANDING OFFICERS, OFFICERS-IN-CHARGE, OR THEIR DESIGNATED REPRESENTATIVE WILL OBTAIN AUTHORIZATION AND QUOTAS FOR TESTING FROM HQMC SUBSTANCE ABUSE SECTION PRIOR TO COLLECTION OF A SYNTHETIC COMPOUND URINE SAMPLE, JUST AS REQUIRED FOR STEROID SAMPLE COLLECTION.  SAMPLES WILL BE COLLECTED USING CURRENT URINALYSIS PROCEDURES, EXCEPT THAT SAMPLES WILL ONLY BE SHIPPED TO THE ARMED FORCES MEDICAL EXAMINER SYSTEM, DOVER AIR FORCE BASE, DELAWARE. SAMPLES SUBMITTED WITHOUT PRIOR AUTHORIZATION FROM HQMC SUBSTANCE ABUSE SECTION WILL NOT BE TESTED. 
5.  CRIMINAL INVESTIGATION DIVISION (CID) AND COMMANDS WILL BE NOTIFIED OF POSITIVE SAMPLES.  FOR EACH POSITIVE SAMPLE:
    A.  CID WILL OPEN AN INVESTIGATION.
    B.  COMMAND MAY TAKE APPROPRIATE ACTIONS RELATED TO HEALTH, SAFETY, AND SECURITY BASED ON POSITIVE RESULTS.
    C.  COMMANDERS MAY CONDUCT FURTHER INQUIRY IF MISCONDUCT IS SUSPECTED.
6.  EXECUTION SPECIFICS FOR URINLAYSIS PROGRAM COORDINATORS, AND FURTHER GUIDANCE TO DRUG DEMAND REDUCTION COORDINATORS, WILL BE PROVIDED VIA SEPARATE CORRESPONDENCE.
7.  RELEASE AUTHORIZED BY BGEN R. F. HEDELUND, DIRECTOR, MARINE AND FAMILY PROGRAMS DIVISION.//